Sophrosyne Technologies

Cover Block

Attribute	Value
Name	Sophrosyne Technologies
Tagline	Fabless semi developing multi-vital biosensing SoCs for wearables
Headquarters	Bengaluru, India
Founded	2022
Stage	Seed
Business Model	Hardware + Software
Industry	Healthtech
Technology	Hardware
Geography	South Asia
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Seed (total disclosed ~$2,000,000)

Links

• Website: https://sophrosynetechnologies.com
• LinkedIn: https://www.linkedin.com/posts/manish-srivastava-386b277_when-jatin-guptaand-i-started-sophrosyne-activity-7398051238443077632-cGRP

Summary and Signal

Sophrosyne Technologies is a Bengaluru-based fabless semiconductor startup building a multi-vital biosensing system-on-chip (SoC), a hardware bet that aims to consolidate the sensor arrays of medical wearables into a single, ultra-low-power piece of silicon [Inc42, November 2025]. Founded in 2022 by Manish Srivastava and Jatin Gupta, the company is pre-revenue and has secured a $2 million seed round led by Bluehill.VC [Inc42, November 2025]. Its product is designed to integrate ECG, PPG, respiration, and temperature monitoring, targeting OEMs that need a compact, energy-efficient solution to accelerate their own device development cycles [Entrackr, November 2025].

The business model is hardware-plus-software, with revenue expected from SoC sales and accompanying AI analytics services. The recent capital infusion, which followed a $1.2 million grant from India's Ministry of Electronics and Information Technology (MeitY), is earmarked for moving from prototype silicon to production and expanding the engineering team [Economic Times, November 2025].

Over the next 12-18 months, the critical milestones to watch are the transition from prototype to production-ready silicon, the announcement of initial design wins or pilot deployments with OEM customers, and any expansion of the team's publicly visible technical leadership. Data Accuracy: YELLOW -- Core funding and product claims are reported consistently across multiple Indian tech publications, but team details and commercial traction are not publicly available.

Company Overview

Sophrosyne Technologies Private Limited was incorporated in 2022, establishing its headquarters in Bengaluru, India [Crunchbase]. The company operates as a fabless semiconductor developer, a model that outsources costly chip fabrication while retaining design and intellectual property control. The founding narrative centers on a technical ambition to create integrated, low-power biosensing silicon for the wearable health market [Inc42, November 2025].

The company's public timeline is anchored by two recent, non-dilutive capital events. In 2025, Sophrosyne secured a $1.2 million grant from the Indian government's MeitY (Ministry of Electronics and Information Technology) Design Linked Incentive scheme [Economic Times, November 2025]. This was followed in November 2025 by a $2 million seed equity round led by the venture firm Bluehill.VC [Inc42, November 2025]. Funds are earmarked for transitioning from prototype silicon to production-scale tape-outs and expanding engineering teams [Entrackr, November 2025]. Data Accuracy: YELLOW -- Company incorporation and funding details are confirmed by multiple Indian business publications; earlier milestones and corporate history are not publicly available.

The Product and the Stack

The company's core offering is a system-on-chip designed to consolidate multiple biosensing modalities into a single, ultra-low-power silicon package for wearable devices. The SoC integrates electrocardiogram (ECG), photoplethysmography (PPG) for heart rate and blood oxygen, respiration, and temperature monitoring [Inc42, November 2025]. The architecture includes on-chip or cloud-based AI for processing the sensor data to generate real-time health insights [Inc42, November 2025].

The business model is fabless semiconductor, targeting original equipment manufacturers (OEMs) and device makers in the digital health space [IPO Platform]. The integrated multi-vital SoC is designed to accelerate time-to-market for OEMs by providing a pre-validated sensing subsystem [Entrackr, November 2025]. The $1.2 million grant from India's Ministry of Electronics and Information Technology (MeitY) under its Design Linked Incentive scheme suggests the prototype has passed a government technical review [Economic Times, November 2025]. Data Accuracy: YELLOW -- Product claims are consistent across multiple Indian tech publications but lack independent technical validation or detailed specification sheets.

The Market They Are Entering

The global market for wearable sensors was valued at $2.2 billion in 2023 and is projected to reach $5.7 billion by 2030, growing at a compound annual rate of 14.5% [Grand View Research, 2024]. The remote patient monitoring market is forecast to exceed $8.5 billion by 2030 [Precedence Research, 2024].

Demand drivers include the global push for decentralized healthcare and regulatory tailwinds, including the U.S. FDA's evolving framework for digital health technologies and India's Production Linked Incentive (PLI) and Design Linked Incentive (DLI) schemes [Economic Times, November 2025]. The primary substitute threat comes from incumbent semiconductor vendors who offer discrete sensor components, though this approach typically consumes more board space and power.

Metric	Value
Wearable Sensors Market 2023	$2.2B
Wearable Sensors Market 2030	$5.7B
Remote Patient Monitoring 2030	$8.5B

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports and are used as analogous indicators.

The Competitive Field

Sophrosyne Technologies enters a hardware market defined by entrenched semiconductor incumbents and a growing field of specialized startups. The competitive map for medical-grade biosensing silicon splits into three tiers: established giants like Texas Instruments and Analog Devices; fabless semiconductor startups focused on health; and software-centric digital health platforms.

Sophrosyne's claimed edge rests on architectural integration and a favorable regulatory and capital environment. By consolidating ECG, PPG, respiration, and temperature onto a single, ultra-low-power SoC, the company aims to reduce the bill-of-materials and design time for OEMs [Inc42, November 2025]. A durable advantage may stem from its early alignment with India's semiconductor incentives, exemplified by the $1.2 million MeitY Design Linked Incentive grant [Entrackr, November 2025]. Data Accuracy: YELLOW -- Competitive mapping is inferred from the general semiconductor and digital health landscape.

Opportunity

The headline opportunity is to become the default biosensing silicon supplier for mid-tier wearable OEMs globally. The multi-vital SoC directly addresses a critical pain point for device manufacturers: integrating discrete sensors increases power consumption, board space, and development complexity [Inc42, November 2025].

Scenario	What happens	Catalyst	Why it's plausible
Domestic standard for RPM devices	Sophrosyne's SoC becomes the preferred silicon for Indian wearable makers building government-tendered remote patient monitoring (RPM) kits.	A strategic partnership with a large Indian OEM or a public health initiative specifying its chip.	The MeitY grant aligns with national semiconductor and health tech self-reliance goals.
Licensing to global consumer health brands	The company's IP is licensed to a major fitness or smartwatch brand seeking medical-grade features for a new product line.	A design win with a second-tier global wearable brand looking to differentiate.	The fabless model is standard for scaling semiconductor IP.

Data Accuracy: YELLOW -- Opportunity framing is extrapolated from cited product claims and funding use-of-funds statements.

Sources

1. [Inc42, November 2025] Semiconductor Startup Sophrosyne Bags $2 Mn From Bluehill VC | https://inc42.com/buzz/semiconductor-startup-sophrosyne-bags-2-mn-from-bluehill-vc/
2. [Entrackr, November 2025] Semiconductor startup Sophrosyne Technologies raises $2 Mn led by Bluehill.VC | https://entrackr.com/snippets/semiconductor-startup-sophrosyne-technologies-raises-2-mn-led-by-bluehillvc-10799138
3. [Economic Times, November 2025] Semiconductor startup Sophrosyne Technologies raises $2 million from Bluehill VC | https://economictimes.indiatimes.com/tech/funding/semiconductor-startup-sophrosyne-technologies-raises-2-million-from-bluehill-vc/articleshow/125466494.cms?from=mdr
4. [Crunchbase] Sophrosyne Technologies - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/sophrosyne-technologies
5. [IPO Platform, 2025] Sophrosyne Technologies latest Startup funding and investors | https://www.ipoplatform.com/startup-business-funding/sophrosyne-technologies-private-limited/100504
6. [sophrosynetechnologies.com] Sophrosyne Technologies - AI-Powered Healthcare & Intelligent Semiconductor Solutions | https://sophrosynetechnologies.com/
7. [Grand View Research, 2024] Wearable Sensors Market Size, Share & Trends Analysis Report, 2030 | https://www.grandviewresearch.com/industry-analysis/wearable-sensors-market
8. [Precedence Research, 2024] Remote Patient Monitoring Market Size, Share, Growth, Report 2032 | https://www.precedenceresearch.com/remote-patient-monitoring-market
9. [Analog Devices, 2022] Analog Devices Completes Acquisition of Maxim Integrated | https://www.analog.com/en/about-adi/news-room/press-releases/2022/8-26-2022-analog-devices-completes-acquisition-of-maxim-integrated.html